Condition
Solid Organ Tumors
Estimated Enrollment: 167
Age Group: 18 Years and older (Adult, Senior)
Gender: All
Study Type: Observational
Study Design Allocation: Time Perspective: Retrospective
Study ID Numbers: PT-207
Study First Received: January 5, 2011
Last Updated: October 4, 2012
Estimated Primary Completion Date: October 2012
Primary Outcome Measures:
To determine physicians’ rate of compliance with ChemoFx assay results in the treatment of subjects with solid tumors.|To investigate the association between the results of Precision’s ChemoFx assay results and overall survival in subjects with solid tumors.
Sponsors and Collaborators:
Precision Therapeutics
Website Link: https://ClinicalTrials.gov/show/NCT01271959
